HC Wainwright & Co. analyst Robert Burns maintains Apollomics (NASDAQ:APLM) with a Buy and lowers the price target from $5 to $2.
HC Wainwright & Co. Maintains Buy on Apollomics, Lowers Price Target to $2
Company Profile